Jane Street Group LLC Takes Position in LifeVantage Co. (NASDAQ:LFVN)

Jane Street Group LLC purchased a new stake in LifeVantage Co. (NASDAQ:LFVN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 34,690 shares of the company's stock, valued at approximately $608,000. Jane Street Group LLC owned approximately 0.28% of LifeVantage as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Schonfeld Strategic Advisors LLC purchased a new stake in LifeVantage in the 4th quarter valued at $282,000. Northern Trust Corp raised its position in LifeVantage by 27.6% in the 4th quarter. Northern Trust Corp now owns 44,176 shares of the company's stock valued at $774,000 after purchasing an additional 9,552 shares during the last quarter. Susquehanna International Group LLP raised its position in LifeVantage by 83.5% during the 4th quarter. Susquehanna International Group LLP now owns 128,082 shares of the company's stock worth $2,245,000 after buying an additional 58,279 shares during the last quarter. EAM Investors LLC purchased a new position in LifeVantage during the 4th quarter worth $1,056,000. Finally, Barclays PLC raised its position in LifeVantage by 3.6% during the 4th quarter. Barclays PLC now owns 43,472 shares of the company's stock worth $763,000 after buying an additional 1,506 shares during the last quarter. 35.32% of the stock is owned by institutional investors and hedge funds.

LifeVantage Stock Performance

LifeVantage stock traded up $0.18 during trading hours on Friday, reaching $12.88. 236,300 shares of the stock were exchanged, compared to its average volume of 143,782. The stock has a market cap of $162.13 million, a P/E ratio of 23.00 and a beta of 0.41. LifeVantage Co. has a 52-week low of $5.22 and a 52-week high of $27.38. The firm's 50 day moving average is $13.27 and its 200 day moving average is $16.27.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.10. The company had revenue of $58.44 million during the quarter, compared to the consensus estimate of $60.99 million. LifeVantage had a net margin of 3.46% and a return on equity of 34.29%.

LifeVantage Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 30th will be issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date of this dividend is Friday, May 30th. This is an increase from LifeVantage's previous quarterly dividend of $0.04. LifeVantage's dividend payout ratio (DPR) is currently 26.09%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.